| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 12/30/2008 | CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 12/29/2008 | CA2610820A1 Method for maintaining physiological ph levels during intensive physical exercise |
| 12/25/2008 | US20080319076 Compositions comprising creatine salts and methods of use thereof |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080318932 Sodium Channel Blocker Compositions and the Use Thereof |
| 12/25/2008 | US20080318884 Methods for Altering Gene Expression and Methods of Treatment Utilizing Same |
| 12/25/2008 | US20080317725 Compositions and methods of treating chronic kidney disease |
| 12/24/2008 | WO2008156685A2 Tendon stem cells |
| 12/24/2008 | WO2008156513A2 Methods to protect skeletal muscle against injury |
| 12/24/2008 | WO2008156418A1 A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
| 12/24/2008 | WO2008155390A2 Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2004176A1 USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | CN100445295C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468188 Multi-step therapy for injured muscles |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/18/2008 | US20080312304 Topical compositions containing metronidazole |
| 12/18/2008 | US20080312180 Methods to Protect Skeletal Muscle Against Injury |
| 12/18/2008 | US20080312175 Methods and compositions for regulating hdac4 activity |
| 12/18/2008 | US20080312129 Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases |
| 12/18/2008 | US20080311622 Activatable recombinant neurotoxins |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/17/2008 | EP2001475A2 Methods for treating sarcopenia with a growth hormone secretagogue |
| 12/17/2008 | EP2001455A2 Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
| 12/17/2008 | EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 12/17/2008 | EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1423106B1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/16/2008 | US7465738 Gene for spinal muscular atrophy |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150477A2 N-acetyl mannosamine as a therapeutic agent |
| 12/11/2008 | WO2008149177A2 Marine lipid compositions and uses thereof |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | WO2008116665A8 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 12/11/2008 | WO2008016669A3 Certain chemical entities, compositions and methods |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | CA2690151A1 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine |
| 12/11/2008 | CA2687866A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | CA2680842A1 N-acetyl mannosamine as a therapeutic agent |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
| 12/10/2008 | EP2000143A2 Transdermal gel compositions containing testosterone and their use for the treatment of fibromyalgia, chronic fatigue syndrome, muscle pain or decreased libido |
| 12/10/2008 | EP1386613B1 Topical effervescent composition |
| 12/10/2008 | CN101318012A Application of beta-inhibited protein 1 in governing survival and autoimmunity of T cell |
| 12/10/2008 | CN101317982A Method for preparing capsule for cooling liver, removing wind, clearing heat and relieving spasm |
| 12/10/2008 | CN100441220C Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
| 12/09/2008 | US7462597 Corticotropin releasing factor 2 receptor agonists |
| 12/09/2008 | US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis |
| 12/09/2008 | CA2417875C Polymorphs of zaleplon and methods for the preparation thereof |
| 12/04/2008 | WO2008067863A3 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 12/04/2008 | US20080300309 Creatine Hydroxycitric Acids Salts and Methods for their Production and use in Individuals |
| 12/04/2008 | US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/03/2008 | EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications |
| 12/03/2008 | EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/03/2008 | EP1996215A2 Metabolic regulators and uses thereof |
| 12/03/2008 | EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/03/2008 | EP1511499B1 Immunomodulatory compounds and methods of use thereof |
| 12/03/2008 | EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 12/03/2008 | EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol |
| 12/03/2008 | EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
| 12/03/2008 | CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/02/2008 | US7459458 Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 12/02/2008 | US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery |
| 12/02/2008 | CA2361841C Mevinolin derivatives |
| 11/27/2008 | WO2008073351A3 Uses of cerberus, coco and derivatives thereof |
| 11/27/2008 | US20080292681 Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage |
| 11/27/2008 | US20080292612 Composition containing several botulic toxins |
| 11/27/2008 | US20080292584 Metaxalone products, method of manufacture, and method of use |
| 11/26/2008 | EP1993555A1 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament |
| 11/26/2008 | EP1414455B1 Isoquinoline inhibitors of p38 |
| 11/26/2008 | EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons |
| 11/26/2008 | CN101312965A Morpholine type cinnamide compound |
| 11/26/2008 | CN101312731A Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 11/26/2008 | CN101312718A Nutraceutical composition for the treatment of muscle wasting |
| 11/26/2008 | CN100436452C Pyrazole compounds useful as protein kinase inhibitors |
| 11/26/2008 | CN100436439C Dimeric isoflavones |
| 11/26/2008 | CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 11/26/2008 | CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 11/26/2008 | CN100435656C Fruit and/or vegetable derived composition |
| 11/25/2008 | US7456253 Growth hormone releasing peptides |